Unfortunately, it would been highly unlikely that the COH would have bought the patents out of the shell. The COH is a research institution and it licenses its IP out, not other IP in. It is possible that another company would have licensed the Chen COH patent then tried to pick up the Race patents, but given the speed that COH works at this would have taken years. The most likely outcome is the patents would have lapsed due to non-payment of the renewal fees and Bisantrene would have been lost forever.
Ann: Zantrene AML trial in Israel advances to Phase 2, page-147
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |